OpenAI and Anthropic join forces against AI-developed biological weapons

General News

Summary

OpenAI and Anthropic are joining other AI leaders to push for stricter U.S. rules on screening synthetic DNA and RNA orders. The letter warns that AI could make it easier for malicious actors to design biological threats and evade existing safeguards. The article also explains how gene-synthesis vendors already use screening software, but current controls are imperfect and some risky sequences can slip through. The story highlights a growing compliance and safety opportunity for providers of biosafety screening, risk-management, and secure AI tooling.

Classifications

industries
Retail
applications
Accounting and Taxes

AskAI Classifications

Labels
SaaS Cloud Computing Enterprise Software

Linked Companies

Microsoft
$1B+
OpenAI
$25M to $50M
Anthropic
$10M to $25M
DeepMind
$100M to $250M